Global Prostate_Specific Membrane Antigen (PSMA) Theranostic Kits Market Report 2025

Item added to cart!

Published : December 2025

Pages : 250

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00 $3367.00

Purchase This Report Download Sample PDF

Purchase This Report

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Global Market Report 2025

Name: Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Global Market Report 2025
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

By Product Type (Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits), By Application (Prostate Cancer, Other Cancers), By End-User (Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Others) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

• Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market size has reached to $0.92 billion in 2024

• Expected to grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%

• Growth Driver: Rising Incidence Of Prostate Cancer Fueling The Growth Of The Market Due To Aging Population And Increasing Disease Burden

• Market Trend: Advanced Diagnostic Kits Support Targeted Therapy And Treatment Planning

• North America was the largest region in 2024.

What Is Covered Under Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

Prostate-specific membrane antigen (PSMA) theranostic kits are specialized tools for the detection and treatment of Prostate Cancer by targeting the PSMA protein highly expressed on cancer cells. They combine a PSMA-targeted imaging agent for accurate tumor localization with a therapeutic component that delivers treatment directly to cancer cells. These kits enable personalized medicine by improving cancer staging, monitoring treatment response, and minimizing damage to healthy tissue.

The main product types of prostate-specific membrane antigen (PSMA) theranostic kits are Diagnostic Kits, therapeutic kits, and combined theranostic kits. Diagnostic kits are tools that detect and visualize PSMA-expressing cancer cells using imaging agents, enabling accurate tumor localization, staging, and monitoring of prostate cancer. These find applications in prostate cancer, and others, serving end-users such as hospitals, diagnostic centers, research institutes, specialty clinics, and others.

Prostate_Specific Membrane Antigen (PSMA) Theranostic Kits Market Size and growth rate 2025 to 2029: Graph

What Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Size and Share 2025?

What Is The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Growth Forecast?

The prostate-specific membrane antigen (PSMA) theranostic kits market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increasing demand for theranostic solutions, growing reimbursement for molecular imaging, rising pharma-academic research collaborations, and growing availability of short-half-life isotopes. Major trends in the forecast period include technology advancements in kit automation, innovations in PSMA ligand design, AI integration for image analysis, technology advancements in isotope production, and innovations in companion diagnostics development.

Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Healthcare Services Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Segmentation

1) By Product Type: Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits

2) By Application: Prostate Cancer, Other Cancers

3) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Others

Subsegments:

1) By Diagnostic Kits: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits

2) By Therapeutic Kits: Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits

3) By Combined Theranostic Kits: Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits

What Is The Driver Of The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

The rising incidence of prostate cancer is expected to propel the growth of the prostate-specific membrane antigen (PSMA) theranostic kits market going forward. Prostate cancer refers to a type of cancer that develops in the prostate gland, a small gland in men located below the bladder and in front of the rectum. The rising prevalence of prostate cancer is due to the aging population, as the risk of developing prostate cancer increases significantly with age. Prostate-specific membrane antigen (PSMA) theranostic kits enhance prostate cancer management by offering targeted diagnostic solutions, making them ideal for early detection and personalized treatment planning. They improve diagnostic accuracy by combining PSMA-specific ligands with radiotracers, supporting better disease monitoring and therapy guidance. For instance, in November 2023, according to the American Cancer Society, a US-based non-profit organization, approximately 313,780 new cases of prostate cancer and 35,770 deaths were estimated in the United States in 2025. Therefore, the rising incidence of prostate cancer is driving the growth of the prostate-specific membrane antigen (PSMA) theranostic kits industry.

Key Players In The Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

Major companies operating in the prostate-specific membrane antigen (psma) theranostic kits Marketare Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, CellBion Co. Ltd., NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, Full-Life Technologies Ltd, AdvanCell Pty Ltd, Alpha-9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, Sinotau Pharmaceutical Group, RadioMedix Inc., Scintomics GmbH, FutureChem Co. Ltd.

Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Trends and Insights

Major companies operating in the prostate-specific membrane antigen (PSMA) theranostic kits market are focusing on developing innovative solutions, such as PSMA-targeted radioligand kits, to meet the rising demand for precision oncology, targeted prostate cancer diagnosis, and therapy. PSMA-targeted radioligand kits are medical kits that combine a ligand specifically designed to bind to Prostate-Specific Membrane Antigen (PSMA) with a radioactive isotope for diagnostic imaging or targeted therapy of prostate cancer. For instance, in March 2025, Telix Pharmaceuticals Limited, an Australia-based radiopharmaceutical company, launched Illuccix, an innovative kit for the preparation of Gallium-68 gozetotide injection. This kit enables hospitals and nuclear medicine facilities to label the radionuclide immediately before injection for PET imaging of PSMA-positive prostate cancer lesions. The kit’s unique features include a ready-to-use preparation format, disease-specific targeting, rapid imaging capability, and compatibility with theranostic workflows, allowing better detection of metastatic lesions, treatment planning, and monitoring therapy response. Its applications include the diagnosis of recurrent or metastatic prostate cancer and guiding personalized treatment decisions, making it a significant advancement over conventional imaging or non-targeted therapies.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

In June 2023, Ariceum Therapeutics GmbH, a Germany-based biotech company, acquired Theragnostics Ltd. for an undisclosed amount. With this acquisition, Ariceum Therapeutics aims to enhance its technological capabilities in PSMA-targeted theranostic kits and expand its radiopharmaceutical portfolio in prostate cancer imaging. Theragnostics Ltd. is a UK-based biopharmaceutical company that develops PSMA-targeted diagnostic kits specifically 68Ga THP PSMA for prostate cancer imaging.

Regional Outlook/Insights

North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2024. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market?

The prostate-specific membrane antigen (PSMA) theranostic kits market consists of sales of radiolabeled therapeutic agents, diagnostic kits, combination theranostic kits, antibody-based PSMA theranostics, PSMA ligand-based drug conjugates, and companion diagnostic kits. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Industry?

The prostate-specific membrane antigen (psma) theranostic kits market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the prostate-specific membrane antigen (psma) theranostic kits industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2025	$1.05 billion
Revenue Forecast In 2034	$1.75 billion
Growth Rate	CAGR of 14.0% from 2025 to 2034
Base Year For Estimation	2024
Actual Estimates/Historical Data	2019-2024
Forecast Period	2025 - 2029 - 2034
Market Representation	Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered	Product Type, Application, End-User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, CellBion Co. Ltd., NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, Full-Life Technologies Ltd, AdvanCell Pty Ltd, Alpha-9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, Sinotau Pharmaceutical Group, RadioMedix Inc., Scintomics GmbH, FutureChem Co. Ltd.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Characteristics

3. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Trends And Strategies

4. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Growth Analysis And Strategic Analysis Framework

5.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Growth Rate Analysis

5.4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Total Addressable Market (TAM)

6. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Segmentation

6.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Diagnostic Kits

Therapeutic Kits

Combined Theranostic Kits

6.2. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate Cancer

Other Cancers

6.3. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Diagnostic Centers

Research Institutes

Specialty Clinics

Others

6.4. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits

Single Photon Emission Computed Tomography Imaging Kits

Companion Diagnostic Kits

Liquid Biopsy Kits

6.5. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Radioligand Therapy Kits

Antibody Based Therapy Kits

Peptide Based Therapy Kits

Small Molecule Therapy Kits

6.6. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Integrated Imaging And Therapy Kits

Dual Function Radiopharmaceutical Kits

Prostate-Specific Membrane Antigen (PSMA) Ligand Based Theranostic Kits

Personalized Treatment Kits

7. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Regional And Country Analysis

7.1. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

8.1. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

9.1. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

9.2. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

10.1. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

11.1. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

11.2. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

12.1. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

13.1. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

14.1. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

14.2. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

15.1. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

15.2. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

16.1. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

17.1. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

18.1. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

19.1. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

20.1. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

21.1. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

21.2. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

22.1. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

23.1. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

23.2. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

24.1. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

24.2. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

25.1. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

25.2. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

26.1. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

26.2. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

27.1. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

28.1. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

28.2. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

29.1. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Overview

29.2. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Landscape And Company Profiles

30.1. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Landscape

30.2. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Company Profiles

30.2.1. Cyclotek (Aust) Pty Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Telix Pharmaceuticals Ltd Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Curium Pharma Overview, Products and Services, Strategy and Financial Analysis

30.2.4. SOFIE Biosciences Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Lantheus Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Other Major And Innovative Companies

31.1. Eckert & Ziegler SE

31.2. CellBion Co. Ltd.

31.3. NorthStar Medical Radioisotopes

31.4. Isotopia Molecular Imaging Ltd

31.5. ITM Isotope Technologies Munich SE

31.6. Full-Life Technologies Ltd

31.7. AdvanCell Pty Ltd

31.8. Alpha-9 Theranostics Inc.

31.9. ABX Advanced Biochemical Compounds GmbH

31.10. Clarity Pharmaceuticals Ltd

31.11. Ariceum Therapeutics GmbH

31.12. Sinotau Pharmaceutical Group

31.13. RadioMedix Inc.

31.14. Scintomics GmbH

31.15. FutureChem Co. Ltd.

32. Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

34. Recent Developments In The Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market

35. Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market High Potential Countries, Segments and Strategies

35.1 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2029 - Countries Offering Most New Opportunities

35.2 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2029 - Segments Offering Most New Opportunities

35.3 Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2019-2024, $ Billion

Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Table 3: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 4: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 5: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 6: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 7: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 8: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 9: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 10: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 11: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 12: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 13: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 14: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 15: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 16: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 17: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 18: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 19: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 20: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 21: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 22: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 23: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 24: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 25: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 26: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 27: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 28: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 29: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 30: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 31: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 32: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 33: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 34: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 35: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 36: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 37: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 38: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 39: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 40: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 41: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 42: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 43: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 44: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 45: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 46: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 47: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 48: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 49: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 50: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 51: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 52: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 53: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 54: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 55: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 56: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 57: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 58: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 59: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 60: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 61: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 62: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 63: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 64: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 65: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 66: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 67: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 68: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 69: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 70: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 71: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 72: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 73: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 74: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 75: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 76: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Table 77: Cyclotek (Aust) Pty Ltd Financial Performance

Table 78: Telix Pharmaceuticals Ltd Financial Performance

Table 79: Curium Pharma Financial Performance

Table 80: SOFIE Biosciences Inc. Financial Performance

Table 81: Lantheus Holdings Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2019-2024, $ Billion

Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion

Figure 3: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 4: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 5: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 6: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Diagnostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 7: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Therapeutic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 8: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Sub-Segmentation Of Combined Theranostic Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 9: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 10: Global Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 11: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 12: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 13: Asia-Pacific, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 14: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 15: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 16: China, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 17: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 18: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 19: India, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 20: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 21: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 22: Japan, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 23: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 24: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 25: Australia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 26: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 27: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 28: Indonesia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 29: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 30: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 31: South Korea, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 32: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 33: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 34: Western Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 35: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 36: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 37: UK, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 38: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 39: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 40: Germany, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 41: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 42: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 43: France, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 44: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 45: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 46: Italy, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 47: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 48: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 49: Spain, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 50: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 51: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 52: Eastern Europe, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 53: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 54: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 55: Russia, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 56: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 57: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 58: North America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 59: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 60: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 61: USA, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 62: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 63: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 64: Canada, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 65: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 66: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 67: South America, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 68: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 69: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 70: Brazil, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 71: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 72: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 73: Middle East, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 74: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 75: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 76: Africa, Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Figure 77: Cyclotek (Aust) Pty Ltd Financial Performance

Figure 78: Telix Pharmaceuticals Ltd Financial Performance

Figure 79: Curium Pharma Financial Performance

Figure 80: SOFIE Biosciences Inc. Financial Performance

Figure 81: Lantheus Holdings Inc. Financial Performance

Top Trends Driving Innovation and Change in the Interstitial Lung Disease Market: Innovative Drug Development Initiatives To Improve Interstitial Lung Disease Treatment

Global Intestinal Pseudo-Obstruction Treatment Market Projected to Reach $30.8 Billion by 2029 at a CAGR of 5.6%

Key Developments and Trends Steering the Intestine Cancer Therapeutics Market Forward: Increasing Focus On Product Approvals To Drive The Revenues

Major Trends and Emerging Patterns in the Intravenous Solutions Market: Innovative Syringes Transforming The Intravenous Solutions Market

A strategic 2025 report providing key insights, trends and forecasts for the global live attenuated polio vaccine market between 2025–2034.

A 2025 forecast report outlining growth projections, key trends and regulatory landscape of the medicated shampoo market through 2029.

A 2025 strategic report on market size, competitive landscape and expansion strategies in the medications for heart failure market.

A forward-looking 2025 report detailing projections, service trends and operational models in the medical accompaniment service market.

Prostate Cancer Diagnostics Global Market Report 2025 – By Products (Instruments, Reagents And Consumables, Accessories), By Test Type (Preliminary Tests, Confirmatory Tests), By Prostate Cancer (Squamous Cell Cancer, Sm...

Prostate Cancer Nuclear Medicine Diagnostics Global Market Report 2025 – By Type (Single Photon Emission Computed Tomography (SPECT), Photon Emission Computed Tomography (PET)), By Test Type (Preliminary Tests, Confirmat...

Prostate Cancer Drugs Global Market Report 2025 – By Type (Hormone Sensitive Prostate Cancer, Hormone Refractory Prostate Cancer), By Therapy (Hormonal Therapy, Chemotherapy, Immunotherapy, Targeted Therapy), By End User...

Drugs For Benign Prostatic hypertrophy Global Market Report 2025 – By Type (Alpha Blocker, 5-alpha Reductase Inhibitor, Phosphodiesterase-5 Inhibitor, Other Types), By Distribution Channel (Hospital Pharmacies, Retail Ph...

Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2025 – By Product (Resectoscopes, Radiofrequency Ablation Device, Urology Lasers, Prostatic Stents, Implants), By Procedure Type (Tr...

Carcinoembryonic Antigen Global Market Report 2025 – By Test Type (Molecular Tests, Serology Tests), By Gender (Male, Female), By Application (Gastrointestinal Cancer, Colorectal Cancer, Pancreatic Cancer, Breast Cancer,...

Urinary Incontinence & Pelvic Organ Prolapse Devices And Equipment Global Market Report 2025 – By Type (Urinary Incontinence Devices, Pelvic Organ Prolapse Devices), By Urinary Incontinence Devices (Artificial Urinary Sp...

Frequently Asked Questions

What is the definition of the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market?

Prostate-specific membrane antigen (PSMA) theranostic kits are specialized tools for the detection and treatment of prostate cancer by targeting the PSMA protein highly expressed on cancer cells. They combine a PSMA-targeted imaging agent for accurate tumor localization with a therapeutic component that delivers treatment directly to cancer cells. These kits enable personalized medicine by improving cancer staging, monitoring treatment response, and minimizing damage to healthy tissue. For further insights on this market, request a sample here

How will the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market drivers and restraints affect the market dynamics? What forces will shape the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits industry going forward?

The market major growth driver - Rising Incidence Of Prostate Cancer Fueling The Growth Of The Market Due To Aging Population And Increasing Disease Burden. For further insights on this market, request a sample here

What is the forecast market size or the forecast market value of the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market?

The prostate-specific membrane antigen (PSMA) theranostic kits market size has grown rapidly in recent years. It will grow from $0.92 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 14.0%. The growth in the historic period can be attributed to growing investment in radiopharmaceutical research and development, rising incidence of prostate cancer, increasing availability of radiochemistry kits, and growing regulatory approvals for diagnostics. The prostate-specific membrane antigen (PSMA) theranostic kits market size is expected to see rapid growth in the next few years. It will grow to $1.75 billion in 2029 at a compound annual growth rate (CAGR) of 13.7%. The growth in the forecast period can be attributed to increasing demand for theranostic solutions, growing reimbursement for molecular imaging, rising pharma-academic research collaborations, and growing availability of short-half-life isotopes. Major trends in the forecast period include technology advancements in kit automation, innovations in PSMA ligand design, AI integration for image analysis, technology advancements in isotope production, and innovations in companion diagnostics development. For further insights on this market, request a sample here

How is the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market segmented?

The prostate-specific membrane antigen (psma) theranostic kits market covered in this report is segmented –
1) By Product Type: Diagnostic Kits, Therapeutic Kits, Combined Theranostic Kits
2) By Application: Prostate Cancer, Other Cancers
3) By End-User: Hospitals, Diagnostic Centers, Research Institutes, Specialty Clinics, Others Subsegments:
1) By Diagnostic Kits: Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography Imaging Kits, Single Photon Emission Computed Tomography Imaging Kits, Companion Diagnostic Kits, Liquid Biopsy Kits
2) By Therapeutic Kits: Radioligand Therapy Kits, Antibody-Based Therapy Kits, Peptide-Based Therapy Kits, Small Molecule Therapy Kits
3) By Combined Theranostic Kits: Integrated Imaging And Therapy Kits, Dual Function Radiopharmaceutical Kits, Prostate-Specific Membrane Antigen (PSMA) Ligand-Based Theranostic Kits, Personalized Treatment Kits For further insights on this market, request a sample here

Which region has the largest share of the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market? What are the other regions covered in the report?

North America was the largest region in the prostate-specific membrane antigen (PSMA) theranostic kits market in 2024. The regions covered in the prostate-specific membrane antigen (psma) theranostic kits market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Who are the major players in the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market?

Major companies operating in the prostate-specific membrane antigen (psma) theranostic kits market are Cyclotek (Aust) Pty Ltd, Telix Pharmaceuticals Ltd, Curium Pharma, SOFIE Biosciences Inc., Lantheus Holdings Inc., Eckert & Ziegler SE, CellBion Co. Ltd., NorthStar Medical Radioisotopes, Isotopia Molecular Imaging Ltd, ITM Isotope Technologies Munich SE, Full‑Life Technologies Ltd, AdvanCell Pty Ltd, Alpha‑9 Theranostics Inc., ABX Advanced Biochemical Compounds GmbH, Clarity Pharmaceuticals Ltd, Ariceum Therapeutics GmbH, Sinotau Pharmaceutical Group, RadioMedix Inc., Scintomics GmbH, FutureChem Co. Ltd. . For further insights on this market, request a sample here.

What are the key trends in the Prostate-Specific Membrane Antigen (PSMA) Theranostic Kits market?

Major trends in this market include Advanced Diagnostic Kits Support Targeted Therapy And Treatment Planning. For further insights on this market, request a sample here.